SPADARO, Aldo
 Distribuzione geografica
Continente #
NA - Nord America 943
EU - Europa 765
AS - Asia 137
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.848
Nazione #
US - Stati Uniti d'America 938
IE - Irlanda 243
SE - Svezia 234
CN - Cina 125
UA - Ucraina 105
DE - Germania 65
GB - Regno Unito 43
FI - Finlandia 37
BE - Belgio 18
IT - Italia 17
IN - India 10
CA - Canada 5
RU - Federazione Russa 2
CL - Cile 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 1.848
Città #
Dublin 243
Jacksonville 214
Chandler 176
Nyköping 127
Beijing 82
Ashburn 70
Ann Arbor 67
Cambridge 38
Princeton 37
Des Moines 31
Medford 30
Lancaster 26
Boardman 23
Dearborn 22
Woodbridge 20
Brussels 18
San Mateo 12
Pune 10
Jinan 9
Mountain View 5
Haikou 4
Changsha 3
Ningbo 3
Norwalk 3
Salerno 3
Taizhou 3
Washington 3
Wilmington 3
Auburn Hills 2
Bolzano 2
Cene 2
Chicago 2
Hangzhou 2
Los Angeles 2
Messina 2
Nanchang 2
Nanjing 2
Ottawa 2
Seattle 2
Shenyang 2
Taiyuan 2
Zhengzhou 2
Ardabil 1
Auckland 1
Boston 1
Bremen 1
Chongqing 1
Fort Payne 1
Fuzhou 1
Granby 1
Guangzhou 1
Hefei 1
Lanzhou 1
Laval 1
Milan 1
Montréal 1
Palermo 1
Phoenix 1
Saint Louis 1
Tianjin 1
Totale 1.331
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 85
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 79
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 78
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 78
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 75
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 68
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 62
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 55
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 55
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. 53
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 53
Ten year follow-up of patients with chronic hepatitis C treated with interferon 52
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 51
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 50
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data 48
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 48
Does malnutrition affect survival in cirrhosis? 47
Farmaci di più comune uso in gastroenterologia 47
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 47
Current practice of hepatitis C treatment in Southern Italy. 47
Toxicity of IFN plus ribavirin in patients with chronic hepatitis C. A multicenter retrospective study 46
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C 46
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 46
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 45
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 44
Cultural representation of newborn feeding 44
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 44
Terapia dell'epatite cronica C: 10 anni di esperienze 42
Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta- analysis of individual patient data 41
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 40
FULMINANT HEPATIC FAILURE AND AUTOIMMUNE DISORDERS IN PATIENT WITH MULTIPLE SCLEROSIS ON INTERFERON BETA 1A: A FATAL COMBINATION? 39
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 38
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 37
Randomized trial of two different daily doses of alpha-interferon versus classical treatment in naive patients with chronic hepatitis C 34
Current practice of chronic hepatitis B treatment in Southern Italy. 34
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. 29
Current practice of hepatitis C treatment in Southern Italy. 29
Totale 1.856
Categoria #
all - tutte 6.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 3 2
2019/2020344 62 29 2 28 1 24 42 33 4 66 51 2
2020/2021238 35 2 50 15 5 36 2 28 3 30 17 15
2021/2022240 2 30 5 14 14 3 8 7 4 42 41 70
2022/2023698 48 64 51 35 62 66 7 52 284 5 19 5
2023/2024156 7 32 10 21 16 45 8 16 0 1 0 0
Totale 1.856